A carregar...

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice

Randomized controlled trials (RCTs) have consistently shown glycemic and extra-glycemic benefits of long-acting injectable glucagon-like-peptide-1 receptor agonists (GLP-1RAs, liraglutide, albiglutide, exenatide once-weekly, dulaglutide, and semaglutide) in terms of reduction in the rates of cardiov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab Syndr Obes
Main Authors: Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665457/
https://ncbi.nlm.nih.gov/pubmed/33204129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S216054
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!